Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy

European Journal of Surgical Oncology

Volumn 35, Issue 2, 2009, Pages 202-208

  Hansson, J ^a   Graf, W ^a   Pahlman L ^a   Nygren, P ^a   Mahteme, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytoreductive surgery; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; TOPOTECAN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CANCER SURVIVAL; CAUTERIZATION; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OPERATION DURATION; OUTCOME ASSESSMENT; OVARY CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 58149512455     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.04.002     Document Type: Article

References (35)

1. Shepherd N., Baxter K., and Love S. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112 (1997) 1096-1102
2. Assersohn L., Norman A., Cunningham D., et al. Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer 79 (1999) 1800-1805
3. Mahteme H., Påhlman L., Glimelius B., and Graf W. Prognosis after surgery in patients with incurable cancer: a population-based study. Br J Surg 83 (1996) 1116-1120
4. Ragnhammar P., Hafström L., Nygren P., et al. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 10 (1992) 904-911
5. Glimelius B. Palliative treatment of patients with colorectal cancer. Scand J Surg 1 (2003) 74-83
6. Witkamp A., Bree E., Kaag M., et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88 (2001) 458-463
7. Mahteme H., and Hansson J. Berglund Å et al. Improved survival in patients with peritoneal metastases from colorectal cancer. A preliminary study. Br J Cancer 90 (2004) 403-407
8. Esquivel J., Sticca R., Sugarbaker P.H., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 14 (2007) 128-133
9. Murphy E., Sexton R., and Moran B. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 50 (2007) 37-42
10. Raspagliesi F., Kusamura S., Campos J.C., et al. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan. Eur J Surg Oncol 32 (2006) 671-675
11. Stephens A.D., Alderman R., Chang D., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann of Surg Oncol 6 (1999) 790-796
12. Jacquet P., and Sugarbaker P.H. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15 (1996) 49-58
13. Gomez-Portilla A., Sugarbaker P.H., and Chang D. Second-look surgery after cytoreductive and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg 23 (1999) 23-29
14. Berthet B., Sugarbaker T.A., Chang D., and Sugarbaker P.H. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 35 (1999) 413-419
15. Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 43 (1999) S15-S25
16. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
17. Sugarbaker P.H. Dissection by electrocautery with a ball tip. J Surg Oncol 56 (1994) 246-248
18. Sobin L.H., and Wittekind C. TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
19. Graf W., Westin J.-E., Påhlman L., and Glimelius B. Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. Int J Colorectal Dis 1 (1994) 35-39
20. Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. A manual for physicians and nurses. 3rd ed. (1998), Ludann, Grand Rapids p. 23
21. Mahteme H., Av H., Grundmark B., et al. Hetrogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis. Eur J Surg Oncol 34 (2008) 547-552
22. Sugarbaker P.H., Jacquet P., Stephens A.D., Stuart O.A., and Averbach A.M. Comparison of covered versus closed technique for heated intraoperative intraperitoneal chemotheraphy for peritoneal carcinomatosis from gastrointestinal cancer. In: Abe O., Inokuchi K., and Takasaki K. (Eds). XXX World Congress of the International College of Surgeons (1996), Monduzzi Editore, Bologna, Italy 389-393
23. Elias D., Bonnay M., Puizillou J.M., et al. Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetic and tissue distribution. Ann Oncol 13 (2002) 267-272
24. NCI DHHS DTCD. Common Terminology Criteria for adverse events v3.0 (CTAE). Cancer Therapy Evaluation Program; 2006.
25. Glehen O., Cotte E., Schreiber V., et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91 (2004) 747-754
26. Younan R., Kusamura S., Baratti D., et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 12 (2005) 910-918
27. Graf W., Ivarsson M., Gerdin B., et al. The influence of early postoperative intraperitoneal chemotherapy on human wound healing. J Surg Res 57 (1994) 394-400
28. Valliant J.C., Nordlinger B., Deuffic S., et al. Adjuvant intraperitoneal 5-fluorouracil in high risk colon cancer. Ann Surg 231 (2000) 449-456
29. Moran B.J., and Cecil T.D. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12 (2003) 585-603
30. Verwaal V.J., van Tinteren H., van Ruth S., and Zoetmulder F.A. Toxcity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85 (2004) 61-67
31. Elias D., Blot F., El Otmany A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
32. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
33. Los G., Verdegaal E., Mutsaers P., and McVie G. Penetration of carboplatin and cisplatin into rat peritoneal tumour nodules after intraperitoneal chemotherapy. Cancer 28 (1991) 159-165
34. Mahteme H., Larsson B., Sundin A., Khamis H., and Graf W. Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery: an autoradiographic study in the rat. Eur J Cancer 40 (2004) 142-147
35. Mahteme H., Larsson B., Sundin A., and Graf W. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat. Anticancer Res 18 (1998) 943-950